Purchase Order N0025922P0160
Award Date 4/22/22
Potential Completion Date 9/14/22
Potential Value $365K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC, a manufacturer of biological threat identification products, for the delivery of respiratory panel test kits and blood culture kits to the Naval Medical Center San Diego. The award, valued at $872,184.98, has an ultimate completion date of September 20, 2023. Biofire Defense LLC has a history of prior prime and subcontract awards from various federal agencies, including the Department of...
- The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
- This is a $99,397.75 firm fixed-price delivery order awarded to Biofire Defense LLC by the Department of the Navy's Bureau of Medicine and Surgery. The contract is for the provision of 30-test Respiratory Panel 2 IVD test kits, with an ultimate completion date of October 14, 2020. The award is under the Multiple Award Schedule (MAS) contract vehicle and is related to the Coronavirus COVID-19 National Interest Action. Biofire Defense is a for-profit limited liability company that has received...
- This $84,649.21 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a biodefense and infectious disease diagnostics company, on September 23, 2022. The contract is for the delivery of RP2.1 DE NOVO PANEL KIT 30 TEST products to the U.S. Naval Hospital in Guam, with a completion date of October 20, 2022. This award is not associated with a set-aside program. Biofire Defense has previously received other prime and subcontract awards from DoD...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostics products. The contract is for the delivery of 62 kits of the Respiratory Panel 2.1 In Vitro Diagnostic (IVD) product, with a potential value of $239,743.46. The place of performance is Salt Lake City, Utah, and the completion date is October 28, 2022. The contract has no...
- The Defense Health Agency (DOD) awarded a $742,431.36 firm fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide Respiratory Panel 2.1 In Vitro Diagnostic tests from November 7, 2022 through January 11, 2023. Biofire Defense LLC will deliver their Biofire Respiratory Panel 2.1 tests, which can rapidly detect more than twenty common respiratory pathogens including influenza A and B, respiratory syncytial virus, rhinovirus/enterovirus, coronavirus...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Biofire Defense LLC, a for-profit limited liability company, for the delivery of 42 kits of the BioFire Global Fever Panel v2.1 IVD, 2 kits of the BioFire SHIELD Control Kit for the Global Fever Panel, and 3 kits of the Respiratory Panel 2.1 IVD. The total ceiling value of this contract is $90,259.00, with a period of performance ending on August 8, 2022. There was no set-aside...
- This contract was awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for 40 respiratory panels at a firm fixed price of $162,285.00, to be delivered by October 15, 2021. The respiratory panels are used to detect respiratory pathogens, including SARS-CoV-2. This contract does not have a set-aside designation. Biofire Defense has previously provided diagnostic assays, test...
- This is a $82,500 firm fixed-price purchase order awarded by the Bureau of South and Central Asian Affairs to Biofire Defense LLC, a for-profit limited liability company that provides biological agent identification products and services. The contract is for the provision of BIOFIRE DEFENSE- RP PANELS- COVID 19 to support COVID-19 response efforts, with a period of performance ending on December 31, 2020. No set-aside designation was used. Biofire Defense has received prior federal contracts and...
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for $632,736.78 to provide a respiratory panel for the Walter Reed National Military Medical Center, with a period of performance through May 25, 2024. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants...
This firm fixed price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC for $365,226. The contract calls for the delivery of 90 Biofire Respiratory Panel 2.1 in vitro diagnostic test kits to aid the Department of Defense's response to the COVID-19 pandemic. Per the terms, Biofire will ship 45 kits on May 18, 2022 and the remaining 45 kits on September 14, 2022 to the Naval Medical Center in San Diego. The original solicitation sought quotes for the 90 Biofire RP2.1 test kits with an expiration date no earlier than March 15, 2023. As the requirement was set aside for small businesses in NAICS code 334516, only firms with 1,000 or fewer employees could compete. No major subcontractors were identified.
Generated 12/29/23, 3:47 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
BIOFIRE Respiratory Panel 2. 1 (RP2. 1) Reagent Kit PRODUCT CODE #423742 (Expiration date of 3/15/2023 or better; IVD Version) Quantity 90 (Deliver 45 each on 5/18/2022 & 9/14/2022) - BRAND NAME Requirement | N0025922Q0031 | Department of the Navy Naval Supply Systems Command | Solicitation 1/1 | 4/4/22, 5:43 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $365.2k | 4/22/22 |